Dr. Robert Fine Speaks at Stockton
Friday, April 26th, 2013
Pictured (l to r) are Dennis Weiss, Abby & Dr. Robert Fine, Dr. Matthew Bonnan, award recipient Radha Varadharajan and Dr. Herman Saatkamp. Photo by Lew Steiner.
Dr. Robert Fine, M.D., a graduate of Stockton College in 1975 and a leading expert on the treatment of pancreatic cancer, presented a free public lecture today at Stockton (Friday, April 26) about the most recent advancements in the fight against the disease.
Dr. Fine, the Herbert Irving Associate Professor of Medicine and Director of Experimental Therapeutics at the Herbert Irving Comprehensive Cancer Center, talked about the role of scientific investigation in advancing treatments for previously intractable medical conditions. Dr. Fine specializes in caring for patients with pancreatic cancer, neuroendocrine cancers, untreatable tumors and brain tumors. His research is focused on developing new experimental therapies.
Fine and his colleagues have developed a new gene therapy for pancreatic cancer and a P53 peptide therapy for mutant P53 cancers, which have been patented and hold great promise as new treatments for cancer.
At the event it was also announced that the School of Natural Sciences and Mathmatics will award the first Dr. Robert L. Fine Award for Student Research to Stockton junior Radha Varadharajan, majoring in biology with a minor in Chemistry and Anthropology. The award was made possible by a gift from Dr. Fine.

GALLOWAY TOWNSHIP, N.J. — Richard Stockton College of New Jersey hosted its annual Professional Achievement Awards on Saturday, Oct. 6, as part of its Homecoming 2012 festivities.




GALLOWAY TOWNSHIP — The Richard Stockton College of New Jersey will host an inspiring photography exhibit called Claiming Citizenship: African Americans and New Deal Photography from Jan. 11-Feb. 28, on the first floor of the college library (E-Wing of the main campus).
The Richard Stockton College of New Jersey received the first outright $1 million gift in its history this week.
ATLANTIC CITY — The future of Atlantic City’s 
